Research Article
Significant Increase in Cytotoxic T Lymphocytes and Natural Killer Cells by Triphala: A Clinical Phase I Study
Table 1
The percentage of lymphocyte subpopulations before and after Triphala ingestion (
).
| Cell types | The percentage of lymphocyte (mean ± SD) | D0 | D7 | D14 | D21 | D28 |
| CD3+CD45+ | 60.56 ± 14.57 | 48.78 ± 12.45a | 55.61 ± 13.22 | 53.82 ± 11.43a | 53.06 ± 10.98a | CD3+CD4+CD45+ | 25.79 ± 9.42 | 18.65 ± 6.02a | 21.49 ± 6.72a | 20.46 ± 6.29a | 19.97 ± 5.60a | CD3+CD8+CD45+ | 26.62 ± 10.21 | 22.77 ± 10.33a | 25.56 ± 11.08 | 25.28 ± 10.91 | 24.73 ± 10.02 | CD3−CD8+CD45+ | 9.48 ± 5.20 | 12.76 ± 5.22 | 11.94 ± 6.14b | 12.10 ± 5.50 | 10.67 ± 4.20 | CD19+CD45+ | 9.94 ± 4.46 | 11.41 ± 5.73 | 11.27 ± 5.58 | 11.56 ± 5.0b | 12.55 ± 5.56b | CD16+56+CD45+ | 30.64 ± 15.34 | 41.16 ± 12.81b | 38.72 ± 12.97b | 38.12 ± 10.62b | 36.88 ± 9.84 | CD25+CD4+CD45+ | 1.88 ± 1.30 | 0.96 ± 0.54a | 2.12 ± 2.07 | 1.31 ± 0.88a | 0.69 ± 0.32a | CD69+CD45+ | 3.27 ± 1.50 | 3.06 ± 1.62 | 3.19 ± 1.74 | 2.60 ± 1.19a | 1.52 ± 0.69a |
|
|
aSignificant decreased, P < 0.05; bSignificant increased, P < 0.05.
|